1
|
Sharma H, Kanwal R, Bhaskaran N and Gupta
S: Plant flavone apigenin binds to nucleic acid bases and reduces
oxidative DNA damage in prostate epithelial cells. PLoS One.
9:e915882014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lu XY, Sun DL, Chen ZJ, Chen T, Li LP, Xu
ZH, Jiang HD and Zeng S: Relative contribution of small and large
intestine to deglycosylation and absorption of flavonoids from
Chrysanthemun morifolium extract. J Agric Food Chem.
58:10661–10667. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Beara IN, Lesjak MM, Jovin ED, Balog KJ,
Anackov GT, Orcić DZ and Mimica-Dukić NM: Plantain (Plantago L.)
species as novel sources of flavonoid antioxidants. J Agric Food
Chem. 57:9268–9273. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kanazawa K, Uehara M, Yanagitani H and
Hashimoto T: Bioavailable flavonoids to suppress the formation of
8-OHdG in HepG2 cells. Arch Biochem Biophys. 455:197–203. 2006.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang YH, Park YS, Kim TJ, Fang LH, Ahn
HY, Hong JT, Kim Y, Lee CK and Yun YP: Endothelium-dependent
vasorelaxant and antiproliferative effects of apigenin. Gen
Pharmacol. 35:341–347. 2000. View Article : Google Scholar
|
6
|
Basile A, Giordano S, López-Sáez JA and
Cobianchi RC: Antibacterial activity of pure flavonoids isolated
from mosses. Phytochemistry. 52:1479–1482. 1999. View Article : Google Scholar
|
7
|
Gupta S, Afaq F and Mukhtar H: Involvement
of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle
arrest and apoptosis by apigenin in human prostate carcinoma cells.
Oncogene. 21:3727–3738. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lindenmeyer F, Li H, Menashi S, Soria C
and Lu H: Apigenin acts on the tumor cell invasion process and
regulates protease production. Nutr Cancer. 39:139–147. 2001.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Jin BH, Qian LB, Chen S, Li J, Wang HP,
Bruce IC, Lin J and Xia Q: Apigenin protects endothelium-dependent
relaxation of rat aorta against oxidative stress. Eur J Pharmacol.
616:200–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Meyer H, Bolarinwa A, Wolfram G and
Linseisen J: Bioavailability of apigenin from apiin-rich parsley in
humans. Ann Nutr Metab. 50:167–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bellosta S, Bogani P, Canavesi M, Galli C
and Visioli F: Mediterranean diet and cardioprotection: Wild
artichoke inhibits metalloproteinase 9. Mol Nutr Food Res.
52:1147–1152. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS
and Kim SJ: Curcumin protects against regional myocardial
ischemia/reperfusion injury through activation of RISK/GSK-3β and
inhibition of p38 MAPK and JNK. J Cardiovasc Pharmacol Ther.
17:387–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yang Y, Hu SJ, Li L and Chen GP:
Cardioprotection by polysaccharide sulfate against
ischemia/reperfusion injury in isolated rat hearts. Acta Pharmacol
Sin. 30:54–60. 2009. View Article : Google Scholar
|
14
|
Schwertz H, Carter JM, Abdudureheman M,
Russ M, Buerke U, Schlitt A, Müller-Werdan U, Prondzinsky R, Werdan
K and Buerke M: Myocardial ischemia/reperfusion causes VDAC
phosphorylation which is reduced by cardioprotection with a p38 MAP
kinase inhibitor. Proteomics. 7:4579–4588. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin M, Lu SS, Wang AX, Qi XY, Zhao D, Wang
ZH, Man MQ and Tu CX: Apigenin attenuates dopamine-induced
apoptosis in melanocytes via oxidative stress-related p38, c-Jun
NH2-terminal kinase and Akt signaling. J Dermatol Sci. 63:10–16.
2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Noh HJ, Sung EG, Kim JY, Lee TJ and Song
IH: Suppression of phorbol-12-myristate-13-acetate-induced tumor
cell invasion by apigenin via the inhibition of p38
mitogen-activated protein kinase-dependent matrix
metalloproteinase-9 expression. Oncol Rep. 24:277–283.
2010.PubMed/NCBI
|
17
|
Huang CH, Kuo PL, Hsu YL, Chang TT, Tseng
HI, Chu YT, Kuo CH, Chen HN and Hung CH: The natural flavonoid
apigenin suppresses Th1- and Th2-related chemokine production by
human monocyte THP-1 cells through mitogen-activated protein kinase
pathways. J Med Food. 13:391–398. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yuan X, Niu HT, Wang PL, et al:
Cardioprotective effect of Licochalcone D against myocardial
ischemia/reperfusion injury in Langendorff-perfused rat hearts.
PLoS One. 10:e01283752015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hu J, Wang Z, Guo YY, Zhang XN, Xu ZH, Liu
SB, Guo HJ, Yang Q, Zhang FX, Sun XL and Zhao MG: A role of
periaqueductal grey NR2B-containing NMDA receptor in mediating
persistent inflammatory pain. Mol Pain. 5:712009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Pagliaro P, Mancardi D, Rastaldo R, Penna
C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA and
Paolocci N: Nitroxyl affords thiol-sensitive myocardial protective
effects akin to early preconditioning. Free Radic Biol Med.
34:33–43. 2003. View Article : Google Scholar
|
21
|
Chen C, Du P and Wang J: Paeoniflorin
ameliorates acute myocardial infarction of rats by inhibiting
inflammation and inducible nitric oxide synthase signaling
pathways. Mol Med Rep. 12:3937–3943. 2015.PubMed/NCBI
|
22
|
Xitao C, Jianping B, Huizhi Z and Kenming
Y: The protective effects of apigenin in myocardium of rats with
ischemia reperfusion injury. J Pharmacology and Clinics of Chinese
Materia Medica. 2:0192011.
|
23
|
Jeyabal PV, Syed MB, Venkataraman M,
Sambandham JK and Sakthisekaran D: Apigenin inhibits oxidative
stress-induced macromolecular damage in N-nitrosodiethylamine
(NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats.
Mol carcinog. 44:11–20. 2005. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Thomas CJ, Ng DC, Patsikatheodorou N,
Limengka Y, Lee MW, Darby IA, Woodman OL and May CN:
Cardioprotection from ischaemia-reperfusion injury by a novel
flavonol that reduces activation of p38 MAPK. Eur J Pharmacol.
658:160–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kaiser RA, Bueno OF, Lips DJ, Doevendans
PA, Jones F, Kimball TF and Molkentin JD: Targeted inhibition of
p38 mitogen-activated protein kinase antagonizes cardiac injury and
cell death following ischemia-reperfusion in vivo. J Biol Chem.
279:15524–15530. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Li G, Barrett EJ, Barrett MO, Cao W and
Liu Z: Tumor necrosis factor-alpha induces insulin resistance in
endothelial cells via a p38 mitogen-activated protein
kinase-dependent pathway. Endocrinology. 148:3356–3363. 2007.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Bassi R, Heads R, Marber MS and Clark JE:
Targeting p38-MAPK in the ischaemic heart: Kill or cure? Curr Opin
Pharmacol. 8:141–146. 2008. View Article : Google Scholar : PubMed/NCBI
|